Russell Investments Group’s Relay Therapeutics RLAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$168K Buy
16,840
+4,378
+35% +$39.2K ﹤0.01% 2901
2025
Q4
$105K Buy
12,462
+23
+0.2% +$164 ﹤0.01% 3038
2025
Q3
$64.9K Sell
12,439
-7,670
-38% -$29.2K ﹤0.01% 3175
2025
Q2
$69.6K Sell
20,109
-19,410
-49% -$57.7K ﹤0.01% 2907
2025
Q1
$104K Sell
39,519
-40,285
-50% -$158K ﹤0.01% 2745
2024
Q4
$329K Buy
79,804
+68,559
+610% +$373K ﹤0.01% 2397
2024
Q3
$79.6K Sell
11,245
-8,182
-42% -$61.1K ﹤0.01% 2704
2024
Q2
$127K Sell
19,427
-160,545
-89% -$1.1M ﹤0.01% 2577
2024
Q1
$1.49M Buy
179,972
+65,484
+57% +$639K ﹤0.01% 1802
2023
Q4
$1.26M Buy
114,488
+108,355
+1,767% +$914K ﹤0.01% 1853
2023
Q3
$51.6K Buy
6,133
+3,033
+98% +$32.6K ﹤0.01% 2749
2023
Q2
$38.9K Buy
+3,100
New +$38.6K ﹤0.01% 2756
2022
Q1
Sell
-871
Closed -$26K 2898
2021
Q4
$26K Hold
871
﹤0.01% 2939
2021
Q3
$27K Buy
+871
New +$29.3K ﹤0.01% 2981
2021
Q2
Sell
-30,134
Closed -$1.04M 3282
2021
Q1
$1.04M Buy
+30,134
New +$1.31M ﹤0.01% 2229

Other funds holding RLAY